Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin Sidechain MVC Daily Trading Volume Surpasses Bitcoin for Several Days, with a Single-Day Peak Reaching 10 Times

Bitcoin Sidechain MVC Daily Trading Volume Surpasses Bitcoin for Several Days, with a Single-Day Peak Reaching 10 Times

币界网币界网2025/05/14 07:34
Show original
According to official news, the Bitcoin ecosystem is witnessing another strong growth point. Influenced by the recent official launch of the decentralized social media network MetaSo, the daily transaction volume of the Bitcoin sidechain MicroVision Chain (MVC) has experienced explosive growth, significantly surpassing the Bitcoin main network for several consecutive days. On-chain data shows that the peak daily transaction volume of MVC was once ten times that of the Bitcoin network during the same period, becoming a focal point of industry attention. 
As an important sidechain of the Bitcoin network, MVC has quickly attracted a large number of developers and users with its core advantages of high concurrency processing capability, efficient confirmation, and low fees. Currently, the MVC ecosystem covers a diverse range of application scenarios, including decentralized exchanges (DEX), cross-chain bridges, and LaunchPAD, and has once advanced to become the seventh largest public chain by computing power globally.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks